Procter & Gamble Hygiene and Health Care Limited Cash Flow Conversion Efficiency
Procter & Gamble Hygiene and Health Care Limited cash flow conversion efficiency. Based on the latest financial reports, Procter & Gamble Hygiene and Health Care Limited (PGHH) has a cash flow conversion efficiency ratio of 0.557x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs5.18 Billion ≈ $56.06 Million USD) by net assets (Rs9.31 Billion ≈ $100.71 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Procter & Gamble Hygiene and Health Care Limited (2004–2026)
Cash flow conversion efficiency of Procter & Gamble Hygiene and Health Care Limited from 2004 to 2026. This chart illustrates how Procter & Gamble Hygiene and Health Care Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. View PGHH live share price for real-time trading data and today's change.
Procter & Gamble Hygiene and Health Care Limited Cash Flow Conversion Ratio Explained
Procter & Gamble Hygiene and Health Care Limited cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Procter & Gamble Hygiene and Health Care Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Procter & Gamble Hygiene and Health Care Limited ranked by their cash flow conversion efficiency. Also see Procter & Gamble Hygiene and Health Care (PGHH) market capitalisation for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Avepoint Inc
NASDAQ:AVPT
|
0.055x |
|
Mr Price Group Ltd
JSE:MRP
|
0.325x |
|
Sopra Steria Group SA
PA:SOP
|
-0.025x |
|
GN Store Nord
CO:GN
|
0.113x |
|
Okeanis Eco Tankers Corp.
NYSE:ECO
|
0.217x |
|
First Busey Corp
NASDAQ:BUSE
|
0.017x |
|
Hamilton Insurance Group, Ltd.
NYSE:HG
|
0.037x |
|
Clariant AG
SW:CLN
|
0.044x |
Annual Cash Flow Conversion Efficiency for Procter & Gamble Hygiene and Health Care Limited (2004–2026)
The table below shows the annual cash flow conversion efficiency of Procter & Gamble Hygiene and Health Care Limited from 2004 to 2026. Review Procter & Gamble Hygiene and Health Care free cash flow efficiency to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2026-06-30 | Rs7.53 Billion ≈ $81.48 Million |
Rs9.24 Billion ≈ $99.94 Million |
1.226x | +46.36% |
| 2025-06-30 | Rs7.37 Billion ≈ $79.70 Million |
Rs6.18 Billion ≈ $66.79 Million |
0.838x | +37.99% |
| 2024-06-30 | Rs7.75 Billion ≈ $83.80 Million |
Rs4.71 Billion ≈ $50.89 Million |
0.607x | -30.43% |
| 2023-06-30 | Rs9.46 Billion ≈ $102.31 Million |
Rs8.26 Billion ≈ $89.30 Million |
0.873x | +12.34% |
| 2022-06-30 | Rs7.38 Billion ≈ $79.77 Million |
Rs5.73 Billion ≈ $61.98 Million |
0.777x | -35.70% |
| 2021-06-30 | Rs7.14 Billion ≈ $77.25 Million |
Rs8.63 Billion ≈ $93.34 Million |
1.208x | +195.15% |
| 2020-06-30 | Rs11.58 Billion ≈ $125.22 Million |
Rs4.74 Billion ≈ $51.27 Million |
0.409x | -9.63% |
| 2019-06-30 | Rs9.09 Billion ≈ $98.31 Million |
Rs4.12 Billion ≈ $44.54 Million |
0.453x | -12.17% |
| 2018-06-30 | Rs8.05 Billion ≈ $87.11 Million |
Rs4.15 Billion ≈ $44.93 Million |
0.516x | -39.05% |
| 2017-06-30 | Rs5.26 Billion ≈ $56.90 Million |
Rs4.45 Billion ≈ $48.15 Million |
0.846x | +261.98% |
| 2016-06-30 | Rs15.11 Billion ≈ $163.43 Million |
Rs3.53 Billion ≈ $38.21 Million |
0.234x | -32.50% |
| 2015-06-30 | Rs12.29 Billion ≈ $132.88 Million |
Rs4.26 Billion ≈ $46.02 Million |
0.346x | +4.25% |
| 2014-06-30 | Rs10.03 Billion ≈ $108.46 Million |
Rs3.33 Billion ≈ $36.04 Million |
0.332x | +156.78% |
| 2013-06-30 | Rs8.05 Billion ≈ $87.09 Million |
Rs1.04 Billion ≈ $11.27 Million |
0.129x | -49.91% |
| 2012-06-30 | Rs6.97 Billion ≈ $75.38 Million |
Rs1.80 Billion ≈ $19.47 Million |
0.258x | +77.44% |
| 2011-06-30 | Rs6.01 Billion ≈ $64.96 Million |
Rs874.39 Million ≈ $9.46 Million |
0.146x | -67.39% |
| 2010-06-30 | Rs5.35 Billion ≈ $57.82 Million |
Rs2.39 Billion ≈ $25.81 Million |
0.446x | +18.66% |
| 2009-06-30 | Rs4.40 Billion ≈ $47.59 Million |
Rs1.66 Billion ≈ $17.91 Million |
0.376x | -1.32% |
| 2008-06-30 | Rs3.47 Billion ≈ $37.49 Million |
Rs1.32 Billion ≈ $14.29 Million |
0.381x | +55.74% |
| 2007-06-30 | Rs2.91 Billion ≈ $31.49 Million |
Rs712.86 Million ≈ $7.71 Million |
0.245x | -52.84% |
| 2006-06-30 | Rs2.73 Billion ≈ $29.49 Million |
Rs1.42 Billion ≈ $15.31 Million |
0.519x | +52.67% |
| 2005-06-30 | Rs2.26 Billion ≈ $24.41 Million |
Rs767.38 Million ≈ $8.30 Million |
0.340x | -21.80% |
| 2004-06-30 | Rs2.49 Billion ≈ $26.94 Million |
Rs1.08 Billion ≈ $11.72 Million |
0.435x | -- |
About Procter & Gamble Hygiene and Health Care Limited
Procter & Gamble Hygiene and Health Care Limited manufactures and sells branded packaged fast-moving consumer goods in the feminine care and healthcare businesses in India and internationally. It operates through Health care Products and Hygiene Products segments. The company offers health care products, including ointments and creams, cough drops, and tablets; and hygiene products, such as femin… Read more